The Victus Femtosecond Laser Platform from Bausch + Lomb has received 510(k) clearance from the FDA for the creation of penetrating arcuate cuts/incisions in the cornea.
Aliso Viejo, CA and Munich-The Victus Femtosecond Laser Platform from Bausch + Lomb has received 510(k) clearance from the FDA for the creation of penetrating arcuate cuts/incisions in the cornea in patients undergoing cataract surgery or other ophthalmic treatment requiring penetrating arcuate cuts/incisions in the cornea. The platform is capable of supporting cataract and corneal procedures on a single platform and offers significant benefits over manual cataract surgery techniques, specifically a higher degree of precision for arcuate incisions.
“With the additional FDA clearance in the United States for arcuate incisions, physicians can now perform multiple sight-enhancing procedures using the Victus platform,” said John Barr, executive vice president and president, Bausch + Lomb Global Surgical. “This clearance enhances our already comprehensive offering in cataract and refractive surgery.”
In other news, Bausch + Lomb has announced “The Ultimate Movie Experience Sweepstakes” to promote a conversation between eye-care professionals and patients about the opportunity to achieve clear, crisp vision, even in low light settings like movie theaters, with PureVision2 or SofLens daily disposable contact lenses.
The Sweepstakes will run through April 28, 2013 and offers physicians educational materials and samples of lenses to help them introduce their patients to the potential of the lenses. Patients who participate have a chance to win one of 10,000 free movie rentals or a weekly drawing for a Samsung HDTV.
For more articles in this issue of Ophthalmology Times eReport, click here.